• 2023 - Launching Linagliptin API with largest manufacturing capacity in the world. Bakul is only manufacturer in the world who is fully backward integrated to make Linagliptin API all the way from very basic chemical stage with >10 steps performed in-house. EU Written confirmation (WC) and WHO-COPP is awarded for Linagliptin

• 2023 - WHO-COPP received for Caffeine, Proxyphylline, Aminophylline and Theophylline Sodium glycinate

• 2022 - Chinese DMF Approval of Pentoxifylline

• 2021 - Korean KDMF approval of Pentoxifylline EP/BP

• 2020 - US FDA approval for Pamabrom USP after inspection of Bakul Aromatics and Chemicals, Patalganga by US FDA

• 2018 - Approval of KDMF for Theobromine EP/BP after GMP inspection of Ankleshwar Plant by MFDS, Korea

• 2018 - Taiwan FDA approval of TDMF for Pentoxifylline EP/BP

• 2017 - Largest manufacturer of xanthine-based Linagliptin Intermediates in the world

• 2016 - EU written confirmation (WC) awarded for Pentoxifylline, Doxofylline and Theobromine

• 2015 - Research Centre received grant from Department of Biotechnology's Biotechnology Industry Research Assistance Council (BIRAC) under the BIPP scheme for the process development of low cost anti-malarial drugs

• 2015 - WHO-GMP granted for Ankleshwar plant with Certificate of Pharmaceutical Product (CoPP) issued for Pentoxifylline, Doxofylline and Theobromine

• 2014 - Drug Master File (DMF) available for Caffeine, Aminophylline, Pentoxifylline, Theophylline, Theobromine, Bamifylline, Doxofylline, Proxiphylline

• 2013 - Manufacturer of Pentoxifylline utilizing in-house Theobromine providing excellent control over quality and production timelines. Capacity expanded to > 75 MT / year

• 2012 - World's largest producer of 3-Methyl Xanthine. Capacity expanded to >300 MT / year

• 2011 - World's largest producer of complete array of Dorzolamide, Valganciclovir and Linagliptin intermediates starting from the basic stages

• 2010 - India’s largest producer of Theophylline, Caffeine and Theobromine, supplying >300 MT/ year of these APIs to consumers all over the world

• 2010 - Production capacity of Doxofylline expanded to > 50 MT / year using in-house Theophylline enabling stringent control of quality and production timelines

• 2009 - Outstanding Export Award from PHARMEXCIL, Export promotion council set up by Ministry of Commerce, Government of India

• 2008 - Status Holder as Export House from Directorate General of Foreign Trade, Minister of Commerce, Government of India

• 2000 - Certificate of Suitability awarded by the European Pharmacoepia Commission for Theophylline

• 1997 - Bakul Pharma Private Limited established with manufacturing facility in Ankleshwar, Gujarat

• 1994 - WHO GMP certificate For Patalganga plant obtained

• 1991 - Awarded the Biennial National Award (1990-1991) by the Prime Minister of India for remarkable achievement in Technology Innovation for the production of Theophylline and Caffeine right from the basic stages

• 1986 - Bakul Aromatics and Chemicals Private Limited plant in GIDC Gowra, Vadodara, Gujarat set up

• 1984 - Bakul Aromatics and Chemicals Private Limited plant in MIDC Patalganga, Maharashtra set up

• 1978 - First manufacturer of large-scale synthetic Caffeine in India using technology developed in-house

• 1975 - Bakul Finechem Research Centre and Bakul Aromatics and Chemicals Private Limited established with manufacturing facility in Navi Mumbai




 

Site Designed by Web Element, Inc